Novel candidates in the clinical development pipeline for TB drug development and their synthetic approaches - Kumar - 2021 - Chemical Biology & Drug Design - Wiley Online Library
SQ109 activity compared with ethambutol in the standard drug regimen... | Download Scientific Diagram
APExBIO - SQ109|Antibiotic for treatment of pulmonary T|CAS# 502487-67-4
Tuberculosis Drugs and Mechanisms of Action | NIH: National Institute of Allergy and Infectious Diseases
Hydroxylation of antitubercular drug candidate, SQ109, by mycobacterial cytochrome P450 | bioRxiv
Proposed sites of action of SQ109 and its analogues. MenA, MenG... | Download Scientific Diagram
Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action. | Semantic Scholar
New agents for the treatment of drug-resistant Mycobacterium tuberculosis - ScienceDirect
SQ109 = 98 HPLC 502487-67-4
Multitarget Drug Discovery for Tuberculosis and Other Infectious Diseases | Journal of Medicinal Chemistry
SQ109 | Infectex
Pharmacokinetics and Target Attainment of SQ109 in Plasma and Human-Like Tuberculosis Lesions in Rabbits | Antimicrobial Agents and Chemotherapy
SQ109 | CAS:502487-67-4 | Antibiotic for treatment of pulmonary T | High Purity | Manufacturer BioCrick
Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action. - Abstract - Europe PMC
SQ109 mechanism of action The figure depicts stylized components of the... | Download Scientific Diagram
SQ109 tissue levels after oral administration to mice for 28 days SQ109... | Download Scientific Diagram
SQ109 mechanism of action The figure depicts stylized components of the... | Download Scientific Diagram
Tuberculosis Drugs and Mechanisms of Action | NIH: National Institute of Allergy and Infectious Diseases
Structure–activity relationship of SQ-109. | Download Scientific Diagram
Biomedicines | Free Full-Text | In Vivo Efficacy of SQ109 against Leishmania donovani, Trypanosoma spp. and Toxoplasma gondii and In Vitro Activity of SQ109 Metabolites | HTML
SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosis | Antimicrobial Agents and Chemotherapy
Strategies towards the synthesis of anti-tuberculosis drugs - Organic & Biomolecular Chemistry (RSC Publishing) DOI:10.1039/C9OB00817A
SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosis | Antimicrobial Agents and Chemotherapy
SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosis | Antimicrobial Agents and Chemotherapy
